About the Company
Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Redwood City, CA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MNLO News
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
Hyperglycemia Glucose metabolism was measured by several diagnostic tests, including the oral glucose tolerance test (glucose ...
ANTX AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical ... The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner
Among Canaan's big Bay Area wins have been migraine drug developer Labrys Biologics, which was sold to Teva Pharmaceuticals ...
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a ...
Corcept Therapeutics Incorporated (CORT)
MENLO PARK, Calif., April 15 ... Portfolio), has recently increased its stake in Corcept Therapeutics Inc (NASDAQ:CORT), a pharmaceutical company specializing in the treatment of severe metabolic ...
Camera store in downtown Menlo Park burglarized
A camera store in downtown Menlo Park had equipment stolen early Tuesday after a car backed into the business.
Menlo-Atherton Little League hosts three evenings “Under the Lights” at Burgess Park
Menlo-Atherton Little League will host three nights of family fun starting Thursday evening, April 25, through Saturday ...
Promising Clinical Outcomes and Market Potential: Buy Rating for Corcept’s Relacorilant
Corcept Therapeutics (CORT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Getting a tour of the new Belle Haven Community Campus before May 18 opening
The new Belle Haven Community Campus (BHCC) will have a grand opening on Saturday, May 18, 2024, with a ribbon cutting ...
Remeditex Ventures LLC's Net Worth
Who is Remeditex Ventures LLC? Remeditex Ventures LLC has an estimated net worth of $208 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics ...
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical ... Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Corcept Therapeutics Incorporated.
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical ... Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Loading the latest forecasts...